Novo Nordisk to discontinue Levemir, impacting patients who rely on its unique dosing flexibility for diabetes management.
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
27 readers recommended
Phase 2 trial of BMF-219 by Biomea Fusion studies insulin sensitivity and beta cell regeneration in Type 1 Diabetes, aiming to transform treatment.
28 readers recommended
Explore Zucara Therapeutics' study on ZT-01, aiming to reduce night-time hypoglycemia in type 1 diabetes by enhancing glucagon production. Join if you meet the criteria.
38 readers recommended
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
93 readers recommended
Glucagon is a hormone produced by the pancreas that raises blood sugar levels by prompting the liver to convert stored glycogen into glucose. It is essential for glucose...
55 readers recommended
Uncover the varied impacts of GLP-1 and incretin therapies on mental health, quality of life, addiction, fatigue, and physical changes.
95 readers recommended
Most people with diabetes know when they are low, but others have difficulty detecting it or are completely unaware. This is known as hypoglycemia unawareness.
67 readers recommended
Temporary shortages of the fast-acting insulin Humalog and its generic version may complicate diabetes care for people using pumps, automated insulin delivery, or on...
39 readers recommended
For the first time, Medicare is allowed to cover Wegovy, but only if prescribed to reduce the risk of serious cardiovascular events.
20 readers recommended
Discover the latest in gestational diabetes management, including CGM technology, screening debates, and possible new treatments like inhaled insulin.
31 readers recommended
The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes.
79 readers recommended
The FDA has approved Wegovy (semaglutide) for reduction of major adverse cardiovascular events (MACE) in people with obesity and overweight and without diabetes, based...
43 readers recommended
In new studies presented at ATTD, CGM used with GLP-1s led to greater A1C reductions than GLP-1s alone.
36 readers recommended
Novo Nordisk’s FLOW trial was stopped early after results showed that Ozempic (semaglutide) slows progression of kidney disease in people with type 2 diabetes and CKD.
20 readers recommended
Exploring metformin as a treatment for gestational diabetes: This article delves into the efficacy, safety, and patient satisfaction of metformin compared to insulin,...
48 readers recommended
A recent study supports the idea that metformin may have a role in dementia prevention. Studies are ongoing to provide a definitive answer.
42 readers recommended
Every February, the Spare a Rose campaign raises funds to provide insulin and other diabetes supplies to people with type 1 in under-resourced countries. Spread the word...
166 readers recommended
Discover the hidden risks of diabetic ketoacidosis (DKA) in insulin-treated diabetes. Learn about euglycemic DKA, triggered by SGLT-2 inhibitors.
26 readers recommended
GLP-1 drugs like Ozempic show promise in addiction treatment, with ongoing research and clinical trials redefining recovery approaches.
38 readers recommended
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted